NeOnc Technologies Holdings, Inc. (NTHI)
5.45
-0.03
(-0.55%)
USD |
NASDAQ |
May 20, 16:00
5.45
0.00 (0.00%)
After-Hours: 20:00
NeOnc Technologies Holdings Cash from Financing (Quarterly) : 7.072M for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| IGC Pharma, Inc. | 0.71M |
| CNS Pharmaceuticals, Inc. | 0.4047M |
| ANI Pharmaceuticals, Inc. | -21.62M |
| Corcept Therapeutics, Inc. | 0.76M |
| Assertio Holdings, Inc. | -0.189M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.992M |
| Free Cash Flow | -22.21M |
| Free Cash Flow Per Share (Quarterly) | -0.3002 |
| Free Cash Flow to Equity (Quarterly) | -1.024M |
| Free Cash Flow to Firm (Quarterly) | -5.817M |
| Free Cash Flow Yield | -19.58% |